-
1 Comment
JiangsuJibeier Pharmaceutical Co., Ltd is currently in a long term downtrend where the price is trading 2.8% below its 200 day moving average.
From a valuation standpoint, the stock is 32.5% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 6.5.
Based on the above factors, JiangsuJibeier Pharmaceutical Co., Ltd gets an overall score of 1/5.
| ISIN | CNE100004041 |
|---|---|
| Exchange | SHG |
| CurrencyCode | CNY |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Beta | 0.42 |
|---|---|
| Market Cap | 5B |
| PE Ratio | 22.17 |
| Target Price | None |
| Dividend Yield | None |
Jiangsu Jibeier Pharmaceutical Co., Ltd., a pharmaceutical company, engages in the research, development, production, and sale of chemical pharmaceutical preparations, Chinese medicine, and drugs. The company's products cover various therapeutic areas, such as improving white blood cells, anti-hypertension, enhancing immunity, treating joint diseases, anti-eye infection, treating bronchitis, protecting liver function, and other therapeutic fields. It is also developing drugs for the treatment of depression, tumors, stomach and gastric diseases, and other diseases. In addition, the company offers its products in tablets, capsules, and eye drops dosage forms. Jiangsu Jibeier Pharmaceutical Co., Ltd. was founded in 2001 and is based in Zhenjiang, China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 688566.SHG using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
